Price versus value
- Price
- $362.25
- Fair value
- $196.19
- Potential value
- $382.12
- As of
- 2026-09-04
Main upside reason
Upside can persist if higher FY2027 revenue and adjusted-EPS expectations are delivered and positive industrial growth improves cost absorption while free cash flow remains positive.
Main risk
The FY2027 analyst-consensus annual revenue estimate falls below $17.00 billion in two consecutive post-event updates.
Sell. The report-date price exceeds Fair value, so the expected recovery does not offset valuation risk.3
The report was prepared at $362.25 on 2026-09-04. Fair value is $196.19, while the secondary Potential value is $382.12 as of 2026-09-08.3
The main risk is the FY2027 revenue estimate falling below $17.00 billion for two consecutive post-event snapshots. Two such readings would signal weaker expected demand. If realized sales then fall, fixed-cost absorption and free cash flow would weaken.